Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.670
+0.015 (0.56%)
Nov 2, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 178.19 million as of November 2, 2026. It is the 37,548th most valuable company in the world and the 520th biggest in Sweden. Its market cap has decreased by 40.59% in one year.
Market Cap
178.19M
Enterprise Value
120.06M
Revenue
7.79M
Global Rank
Country Rank
#520 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 178.19M, an increase of 45.28%. That is a compound annual growth rate of 7.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 178.19M | -29.67% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 287.57M |
| Xbrane Biopharma AB | 265.81M |
| Intervacc AB | 263.11M |
| Simris Group AB (PUBL) | 159.28M |
| Diamyd Medical AB | 155.29M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 134.36M |
| Initiator Pharma | 129.03M |